Skip to main content
. 2013 Feb;5(1):45–54. doi: 10.1177/1759720X12468658

Figure 2.

Figure 2.

ASAS recommendations for the use of an anti-TNF agent in patients with axial SpA.

AS, ankylosing spondylitis; ASAS, Assessment of Spondyloarthritis International Society; BASDAI, the Bath Ankylosing Spondylitis Disease Activity Index; CRP, C-reactive protein; DMARD, disease-modifying antirheumatic drug; ESR, erythrocyte sedimentation rate; MRI, magnetic resonance imaging; NSAID, nonsteroidal anti-inflammatory drug; SpA, spondyloarthritis; TNF, tumour necrosis factor.